Global Cholesterol Lowering Biologic Drugs Market Research Report 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 93

Report ID: 12600

The cholesterol lowering biologic drugs offers a new, revolutionary alternative for people fighting with cholesterol with the same old treatments. The old method of treating cholesterol elevated levels includes a change in diet and consuming statin pills to prevent the body from making more bad cholesterol. The new class of PCSK-9 inhibitors is being approved by the FDA which works by helping the liver flush out the bad cholesterol instead of preventing the body from making low-density lipoproteins. The FDA has till now approved only two drugs Praluent and Repatha, both made from living things. The PCSK-9 is a protein which binds to the receptors, those which are responsible for getting the bad cholesterol out of the body.
The cholesterol lowering biologics drug market is expected to boom owing to the number of population with high cholesterol levels, sedentary lifestyle and increasing research developments. According to the Indian Council of Medical Research, at least three-fourth of the country’s population has dyslipidemia, a condition where the individual has abnormal levels of triglycerides or cholesterol. The risk factors are obesity, hypertension poor lifestyle habits and diabetes. Moreover, the demand for biologics is driven by the dramatic shift in production technology and an expansion of targeted diseases.

The global Cholesterol Lowering Biologic Drugs market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Cholesterol Lowering Biologic Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Cholesterol Lowering Biologic Drugs market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
Amgen
Regeneron Pharmaceuticals
Alnylam Pharmaceuticals
...

Segment by Regions
North America
Europe
China
Japan

Segment by Type
For Oral Administration
Injectable Drugs

Segment by Application
Hospital Pharmacies
Retail Pharmacies
Drug Stores
Online Sales

Table of Contents

Executive Summary
1 Cholesterol Lowering Biologic Drugs Market Overview
1.1 Product Overview and Scope of Cholesterol Lowering Biologic Drugs
1.2 Cholesterol Lowering Biologic Drugs Segment by Type
1.2.1 Global Cholesterol Lowering Biologic Drugs Production Growth Rate Comparison by Type (2014-2025)
1.2.2 For Oral Administration
1.2.3 Injectable Drugs
1.3 Cholesterol Lowering Biologic Drugs Segment by Application
1.3.1 Cholesterol Lowering Biologic Drugs Consumption Comparison by Application (2014-2025)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Drug Stores
1.3.5 Online Sales
1.4 Global Cholesterol Lowering Biologic Drugs Market by Region
1.4.1 Global Cholesterol Lowering Biologic Drugs Market Size Region
1.4.2 North America Status and Prospect (2014-2025)
1.4.3 Europe Status and Prospect (2014-2025)
1.4.4 China Status and Prospect (2014-2025)
1.4.5 Japan Status and Prospect (2014-2025)
1.5 Global Cholesterol Lowering Biologic Drugs Market Size
1.5.1 Global Cholesterol Lowering Biologic Drugs Revenue (2014-2025)
1.5.2 Global Cholesterol Lowering Biologic Drugs Production (2014-2025)

2 Global Cholesterol Lowering Biologic Drugs Market Competition by Manufacturers
2.1 Global Cholesterol Lowering Biologic Drugs Production Market Share by Manufacturers (2014-2019)
2.2 Global Cholesterol Lowering Biologic Drugs Revenue Share by Manufacturers (2014-2019)
2.3 Global Cholesterol Lowering Biologic Drugs Average Price by Manufacturers (2014-2019)
2.4 Manufacturers Cholesterol Lowering Biologic Drugs Production Sites, Area Served, Product Types
2.5 Cholesterol Lowering Biologic Drugs Market Competitive Situation and Trends
2.5.1 Cholesterol Lowering Biologic Drugs Market Concentration Rate
2.5.2 Cholesterol Lowering Biologic Drugs Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Cholesterol Lowering Biologic Drugs Production Market Share by Regions
3.1 Global Cholesterol Lowering Biologic Drugs Production Market Share by Regions
3.2 Global Cholesterol Lowering Biologic Drugs Revenue Market Share by Regions (2014-2019)
3.3 Global Cholesterol Lowering Biologic Drugs Production, Revenue, Price and Gross Margin (2014-2019)
3.4 North America Cholesterol Lowering Biologic Drugs Production
3.4.1 North America Cholesterol Lowering Biologic Drugs Production Growth Rate (2014-2019)
3.4.2 North America Cholesterol Lowering Biologic Drugs Production, Revenue, Price and Gross Margin (2014-2019)
3.5 Europe Cholesterol Lowering Biologic Drugs Production
3.5.1 Europe Cholesterol Lowering Biologic Drugs Production Growth Rate (2014-2019)
3.5.2 Europe Cholesterol Lowering Biologic Drugs Production, Revenue, Price and Gross Margin (2014-2019)
3.6 China Cholesterol Lowering Biologic Drugs Production (2014-2019)
3.6.1 China Cholesterol Lowering Biologic Drugs Production Growth Rate (2014-2019)
3.6.2 China Cholesterol Lowering Biologic Drugs Production, Revenue, Price and Gross Margin (2014-2019)
3.7 Japan Cholesterol Lowering Biologic Drugs Production (2014-2019)
3.7.1 Japan Cholesterol Lowering Biologic Drugs Production Growth Rate (2014-2019)
3.7.2 Japan Cholesterol Lowering Biologic Drugs Production, Revenue, Price and Gross Margin (2014-2019)

4 Global Cholesterol Lowering Biologic Drugs Consumption by Regions
4.1 Global Cholesterol Lowering Biologic Drugs Consumption by Regions
4.2 North America Cholesterol Lowering Biologic Drugs Consumption (2014-2019)
4.3 Europe Cholesterol Lowering Biologic Drugs Consumption (2014-2019)
4.4 China Cholesterol Lowering Biologic Drugs Consumption (2014-2019)
4.5 Japan Cholesterol Lowering Biologic Drugs Consumption (2014-2019)

5 Global Cholesterol Lowering Biologic Drugs Production, Revenue, Price Trend by Type
5.1 Global Cholesterol Lowering Biologic Drugs Production Market Share by Type (2014-2019)
5.2 Global Cholesterol Lowering Biologic Drugs Revenue Market Share by Type (2014-2019)
5.3 Global Cholesterol Lowering Biologic Drugs Price by Type (2014-2019)
5.4 Global Cholesterol Lowering Biologic Drugs Production Growth by Type (2014-2019)

6 Global Cholesterol Lowering Biologic Drugs Market Analysis by Applications
6.1 Global Cholesterol Lowering Biologic Drugs Consumption Market Share by Application (2014-2019)
6.2 Global Cholesterol Lowering Biologic Drugs Consumption Growth Rate by Application (2014-2019)

7 Company Profiles and Key Figures in Cholesterol Lowering Biologic Drugs Business
7.1 Amgen
7.1.1 Amgen Cholesterol Lowering Biologic Drugs Production Sites and Area Served
7.1.2 Cholesterol Lowering Biologic Drugs Product Introduction, Application and Specification
7.1.3 Amgen Cholesterol Lowering Biologic Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.1.4 Main Business and Markets Served
7.2 Regeneron Pharmaceuticals
7.2.1 Regeneron Pharmaceuticals Cholesterol Lowering Biologic Drugs Production Sites and Area Served
7.2.2 Cholesterol Lowering Biologic Drugs Product Introduction, Application and Specification
7.2.3 Regeneron Pharmaceuticals Cholesterol Lowering Biologic Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.2.4 Main Business and Markets Served
7.3 Alnylam Pharmaceuticals
7.3.1 Alnylam Pharmaceuticals Cholesterol Lowering Biologic Drugs Production Sites and Area Served
7.3.2 Cholesterol Lowering Biologic Drugs Product Introduction, Application and Specification
7.3.3 Alnylam Pharmaceuticals Cholesterol Lowering Biologic Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.3.4 Main Business and Markets Served

8 Cholesterol Lowering Biologic Drugs Manufacturing Cost Analysis
8.1 Cholesterol Lowering Biologic Drugs Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Cholesterol Lowering Biologic Drugs
8.4 Cholesterol Lowering Biologic Drugs Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.2 Cholesterol Lowering Biologic Drugs Distributors List
9.3 Cholesterol Lowering Biologic Drugs Customers

10 Market Dynamics
10.1 Market Trends
10.2 Opportunities
10.3 Market Drivers
10.4 Challenges
10.5 Influence Factors

11 Global Cholesterol Lowering Biologic Drugs Market Forecast
11.1 Global Cholesterol Lowering Biologic Drugs Production, Revenue Forecast
11.1.1 Global Cholesterol Lowering Biologic Drugs Production Growth Rate Forecast (2019-2025)
11.1.2 Global Cholesterol Lowering Biologic Drugs Revenue and Growth Rate Forecast (2019-2025)
11.1.3 Global Cholesterol Lowering Biologic Drugs Price and Trend Forecast (2019-2025)
11.2 Global Cholesterol Lowering Biologic Drugs Production Forecast by Regions (2019-2025)
11.2.1 North America Cholesterol Lowering Biologic Drugs Production, Revenue Forecast (2019-2025)
11.2.2 Europe Cholesterol Lowering Biologic Drugs Production, Revenue Forecast (2019-2025)
11.2.3 China Cholesterol Lowering Biologic Drugs Production, Revenue Forecast (2019-2025)
11.2.4 Japan Cholesterol Lowering Biologic Drugs Production, Revenue Forecast (2019-2025)
11.3 Global Cholesterol Lowering Biologic Drugs Consumption Forecast by Regions (2019-2025)
11.3.1 North America Cholesterol Lowering Biologic Drugs Consumption Forecast (2019-2025)
11.3.2 Europe Cholesterol Lowering Biologic Drugs Consumption Forecast (2019-2025)
11.3.3 China Cholesterol Lowering Biologic Drugs Consumption Forecast (2019-2025)
11.3.4 Japan Cholesterol Lowering Biologic Drugs Consumption Forecast (2019-2025)
11.4 Global Cholesterol Lowering Biologic Drugs Production, Revenue and Price Forecast by Type (2019-2025)
11.5 Global Cholesterol Lowering Biologic Drugs Consumption Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer